Boothbay Fund Management, LLC Bristol Myers Squibb CO Call Options Transaction History

Boothbay Fund Management, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $533 - $315,044	4,100 Added 136.67%	7,100 $505,000
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $508,340 - $559,860	-7,000 Reduced 70.0%	3,000 $231,000
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $399,620 - $479,180	-6,500 Reduced 39.39%	10,000 $730,000
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $884,895 - $1.03 Million	16,500 New	16,500 $1.03 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.